Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorbinil Retinopathy Trial
NCT00000159Phase 3Completed
- Sponsor
- National Eye Institute
- Start
- Aug 1983
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in diabetic retinopathy (DR) and diabetic neuropathy comparing Sorbinil with Placebo (2 arms). Primary endpoint: Worsening of retinopathy severity grade by two or more levels at 41 months. Started Aug 1983; status: completed.
02
Drugs
sorbinil
03
Conditions
diabetic retinopathy (DR)diabetic neuropathy
Beyond the preview
Go deeper on NCT00000159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000159.